查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
鼻竇炎治療的全球市場:現狀分析、預測 (2022年～2028年)
市場調查報告書
商品編碼
1241362

鼻竇炎治療的全球市場:現狀分析、預測 (2022年～2028年)

Global Sinusitis Treatment Market: Current Analysis and Forecast (2022-2028)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 135 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

鼻竇炎治療的需求高漲，起因於鼻竇炎的盛行率全球增加。還有新藥的R&D投資持續增加也成為市場顯著成長的要素。再加上診斷藥的需求高漲，市場規模在預測期間內，預計以5％的年複合成長率成長。

本報告提供全球鼻竇炎治療的市場調查，市場定義和概要，市場成長的各種影響因素分析，市場規模的變化、預測，各種區分、各地區/主要國家的明細，法律制度，供需趨勢，競爭環境，主要企業簡介等彙整資訊。

目錄

第1章 簡介

第2章 調查手法、前提條件

第3章 市場概要

第4章 摘要整理

第5章 COVID-19:對鼻竇炎治療市場的影響

第6章 鼻竇炎治療市場:收益的變化、預測

第7章 市場洞察:各疾病

  • 急性鼻竇炎
  • 亞急性鼻竇炎
  • 慢性鼻竇炎

第8章 市場洞察:各治療法

  • 止痛藥
  • 抗組織胺藥物
  • 皮質類固醇
  • 抗生素
  • 手術

第9章 市場洞察:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第10章 鼻竇炎治療市場:市場動態

  • 推動市場要素
  • 市場課題
  • 影響分析

第11章 鼻竇炎治療市場:市場機會

第12章 鼻竇炎治療市場:市場趨勢

第13章 需求側、供給側的分析

第14章 價值鏈分析

第15章 競爭模式

第16章 企業概要

  • Olympus Corporation
  • Medtronic
  • Stryker
  • Cipla Inc.
  • Dr. Reddy's Laboratories Ltd
  • Sanofi
  • Aurobindo Pharma
  • Intersect ENT, Inc.
  • Smith+Nephew
  • Novartis AG

第17章 免責聲明

簡介目錄
Product Code: UMME211679

Sinusitis is a medical condition that causes inflammation along the sinus lining, which can cause symptoms like facial pain, sinus headaches, breathing problems, fatigue, tooth pain, and a loss of taste and smell. The growing demand for sinus treatment can be attributed to the increasing prevalence of rhinosinusitis across the globe. For instance, according to the World Allergy Organization 2021, the worldwide prevalence of chronic rhinosinusitis (CRS) ranges from about 8% in China, 8.4% in Korea, 11% in Europe, and 12% in the United States. Furthermore, the increasing investments in the research and development of novel medicines also attributes to the significant growth of the market.

The increasing demand for diagnostics is expected to drive the global sinusitis treatment market at a CAGR of 5%, during the forecast period. Factors such as rapid technological advancement and integration of information technology in healthcare are important factors responsible for the market growth of the sinusitis treatment market.

Based on the disease, the market has been categorized into acute sinusitis, sub-acute sinusitis, and chronic sinusitis. Among them, the chronic sinusitis segment holds a considerable share of the market. The rising incidences of chronic sinusitis along with the rise in air pollution are the important factors contributing to the share of the chronic sinusitis segment. For instance, according to the National Institute of Allergy and Infectious Diseases (NIAID), an estimated 134 million Indians suffer from chronic sinusitis.

Based on the treatment, the market has been categorized into analgesics, antihistamines, corticosteroids, antibiotics, and surgery. Among them, the antibiotics segment holds a considerable share of the market. The increasing prevalence of high effectiveness of the antibodies against them attributes to the significant share of the antibodies in the sinusitis treatment.

For a better understanding of the market adoption of the sinusitis treatment, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America is anticipated to hold a considerable market share during the forecast period. The rising number of sinusitis cases along with the presence of a large geriatric population in the region attributes to the significant share of sinusitis treatment. For instance, according to the University of Michigan Health Michigan Medicines, Chronic sinusitis affects 31 million people in the U.S. and accounts for more than 16 million outpatient visits a year.

Some of the major players operating in the market are Olympus Corporation; Medtronic; Stryker; Cipla Inc.; Dr. Reddy's Laboratories Ltd; Sanofi; Aurobindo Pharma; Intersect ENT, Inc.; Smith+Nephew; and Novartis AG

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Sinusitis Treatment Market
  • 2.2. Research Methodology of the Sinusitis Treatment Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE SINUSITIS TREATMENT MARKET

6 SINUSITIS TREATMENT MARKET REVENUE (USD BN), 2020-2028F

7 MARKET INSIGHTS BY DISEASE

  • 7.1. Acute Sinusitis
  • 7.2. Sub-acute Sinusitis
  • 7.3. Chronic Sinusitis

8 MARKET INSIGHTS BY TREATMENT

  • 8.1. Analgesics
  • 8.2. Antihistamines
  • 8.3. Corticosteroids
  • 8.4. Antibiotics
  • 8.5. Surgery

9 MARKET INSIGHTS BY REGION

  • 9.1. North America
    • 9.1.1. U.S.
    • 9.1.2. Canada
    • 9.1.3. Rest of North America
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. U.K.
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Rest of Asia-Pacific
  • 9.4. Rest of World

10 SINUSITIS TREATMENT MARKET DYNAMICS

  • 10.1. Market Drivers
  • 10.2. Market Challenges
  • 10.3. Impact Analysis

11 SINUSITIS TREATMENT MARKET OPPORTUNITIES

12 SINUSITIS TREATMENT MARKET TRENDS

13 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 13.1. Demand Side Analysis
  • 13.2. Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 COMPETITIVE SCENARIO

  • 15.1. Competitive Landscape
    • 15.1.1. Porters Fiver Forces Analysis

16 COMPANY PROFILED

  • 16.1. Olympus Corporation
  • 16.2. Medtronic
  • 16.3. Stryker
  • 16.4. Cipla Inc.
  • 16.5. Dr. Reddy's Laboratories Ltd
  • 16.6. Sanofi
  • 16.7. Aurobindo Pharma
  • 16.8. Intersect ENT, Inc.
  • 16.9. Smith+Nephew
  • 16.10. Novartis AG

17 DISCLAIMER